Expertise in
9
conditions

Dr. Emmanuel Mignot

Sleep Medicine
Stanford University Medical Center
450 Broadway St, 
Redwood City, CA 
Expertise in
9
conditions
Stanford University Medical Center
450 Broadway St, 
Redwood City, CA 

Overview

Emmanuel Mignot is a Sleep Medicine provider practicing medicine in Redwood City, California.

Dr. Mignot is highly rated in 9 conditions, according to our data. His clinical expertise encompasses Narcolepsy, Drowsiness, Excessive Daytime Sleepiness, and Idiopathic Hypersomnia.

He is actively involved in clinical research, co-authoring 264 peer reviewed articles and participating in 7 clinical trials.

Specialties

Sleep Medicine

Licenses

Psychiatry & Neurology in CA

Languages Spoken

English

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO

Locations

Stanford University Medical Center
450 Broadway St, Redwood City, CA 94063
Other Locations
Stanford Hospital and Clinics
965 High St, Palo Alto, CA 94301

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

7 Clinical Trials

A Phase 2, Double-blind, Placebo-controlled, Parallel-group, Multicenter Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of 2 mg and 4 mg SUVN-G3031 Compared to Placebo in Patients With Narcolepsy With and Without Cataplexy
A Phase 2, Double-blind, Placebo-controlled, Parallel-group, Multicenter Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of 2 mg and 4 mg SUVN-G3031 Compared to Placebo in Patients With Narcolepsy With and Without Cataplexy
Enrollment Status: Completed
Publish Date: January 13, 2025
Intervention Type: Drug
Study Drug: SUVN-G3031
Study Phase: Phase 2
A Randomized, Double-Blind, Placebo-Controlled, Multiple Rising Oral Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of TAK-994 in Patients With Narcolepsy With or Without Cataplexy (Narcolepsy Type 1 or Narcolepsy Type 2)
A Randomized, Double-Blind, Placebo-Controlled, Multiple Rising Oral Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of TAK-994 in Patients With Narcolepsy With or Without Cataplexy (Narcolepsy Type 1 or Narcolepsy Type 2)
Enrollment Status: Terminated
Publish Date: October 29, 2024
Intervention Type: Drug
Study Drug: TAK-994
Study Phase: Phase 2
A Double-Blind, Placebo-Controlled, Randomized Withdrawal Study to Evaluate the Safety and Efficacy of Pitolisant in Adult Patients With Idiopathic Hypersomnia
A Double-Blind, Placebo-Controlled, Randomized Withdrawal Study to Evaluate the Safety and Efficacy of Pitolisant in Adult Patients With Idiopathic Hypersomnia
Enrollment Status: Completed
Publish Date: September 19, 2024
Intervention Type: Drug
Study Phase: Phase 3
A Dose-Blind Extension Study With Double-blind, Placebo-Controlled, Randomized Withdrawal Period to Evaluate the Safety and Explore the Pharmacokinetics and Pharmacodynamics of TAK-994 in Adults With Narcolepsy With Cataplexy (Narcolepsy Type 1)
A Dose-Blind Extension Study With Double-blind, Placebo-Controlled, Randomized Withdrawal Period to Evaluate the Safety and Explore the Pharmacokinetics and Pharmacodynamics of TAK-994 in Adults With Narcolepsy With Cataplexy (Narcolepsy Type 1)
Enrollment Status: Terminated
Publish Date: December 26, 2023
Intervention Type: Drug
Study Phase: Phase 2
A Study to Assess the Frequency and Characteristics of Wake and Sleep State Transitions Over Multiple Nights in Subjects With Narcolepsy Type 1 Compared With Healthy Subjects Using a Portable Electroencephalogram Device
A Study to Assess the Frequency and Characteristics of Wake and Sleep State Transitions Over Multiple Nights in Subjects With Narcolepsy Type 1 Compared With Healthy Subjects Using a Portable Electroencephalogram Device
Enrollment Status: Completed
Publish Date: May 07, 2021
Intervention Type: Device
A Double-Blind, Placebo-Controlled, Randomized-Withdrawal, Multicenter Study of the Efficacy and Safety of JZP-258 in Subjects With Narcolepsy With Cataplexy
A Double-Blind, Placebo-Controlled, Randomized-Withdrawal, Multicenter Study of the Efficacy and Safety of JZP-258 in Subjects With Narcolepsy With Cataplexy
Enrollment Status: Completed
Publish Date: November 12, 2020
Intervention Type: Drug, Other
Study Phase: Phase 3
A Randomized, Placebo-Controlled, Double-blind, Fixed-Dose, Multiple Cohort, Multiple Crossover, Dose-Finding Study of Oral BTD-001 in Adults With Idiopathic Hypersomnia (IH) or Narcolepsy Type 2
A Randomized, Placebo-Controlled, Double-blind, Fixed-Dose, Multiple Cohort, Multiple Crossover, Dose-Finding Study of Oral BTD-001 in Adults With Idiopathic Hypersomnia (IH) or Narcolepsy Type 2
Enrollment Status: Completed
Publish Date: January 16, 2019
Intervention Type: Drug
Study Phase: Phase 2
View 6 Less Clinical Trials

263 Total Publications

Brain Health from Sleep EEG: A Multicohort, Deep Learning Biomarker for Cognition, Disease, and Mortality.
Brain Health from Sleep EEG: A Multicohort, Deep Learning Biomarker for Cognition, Disease, and Mortality.
Journal: NEJM AI
Published: April 09, 2026
Similar Doctors
Expertise in
11
conditions
Dr. Clete Kushida
Sleep Medicine
Expertise in
11
conditions
Dr. Clete Kushida
Sleep Medicine

Stanford University Medical Center

450 Broadway St, 
Redwood City, CA 
 (0.1 miles away)
650-723-6601
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Clete Kushida is a Sleep Medicine provider practicing medicine in Redwood City, California. Dr. Kushida is highly rated in 11 conditions, according to our data. His clinical expertise encompasses Obstructive Sleep Apnea, Drowsiness, Excessive Daytime Sleepiness, Adenoidectomy, and Deep Brain Stimulation.

Expertise in
28
conditions
Dr. Mitchell Miglis
Sleep Medicine
Expertise in
28
conditions
Dr. Mitchell Miglis
Sleep Medicine

Stanford University Medical Center

450 Broadway St, 
Redwood City, CA 
 (0.1 miles away)
650-723-6601
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Mitchell Miglis is a Sleep Medicine provider practicing medicine in Redwood City, California. Dr. Miglis is highly rated in 28 conditions, according to our data. His clinical expertise encompasses Familial Dysautonomia, Orthostatic Hypotension, Low Blood Pressure, Postural Orthostatic Tachycardia Syndrome (POTS), and Tissue Biopsy.

Expertise in
7
conditions
Dr. Robson Capasso
Sleep Medicine
Expertise in
7
conditions
Dr. Robson Capasso
Sleep Medicine

Stanford University Medical Center

450 Broadway St, 
Redwood City, CA 
 (0.1 miles away)
650-723-5281
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Robson Capasso is a Sleep Medicine provider practicing medicine in Redwood City, California. Dr. Capasso is highly rated in 7 conditions, according to our data. His clinical expertise encompasses Obstructive Sleep Apnea, Nasal Septal Hematoma, Low Nasal Bridge, Septoplasty, and Osteotomy.

Frequently Asked Questions about Dr. Emmanuel Mignot

How do I make an appointment with Dr. Emmanuel Mignot?

You can book an appointment with Dr. Emmanuel Mignot by calling their office at 650-723-6601. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Emmanuel Mignot a top-rated expert for Narcolepsy?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Emmanuel Mignot is classified as an Elite expert for Narcolepsy, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Emmanuel Mignot specialize in?

While Dr. Emmanuel Mignot is a Sleep Medicine, they have specific expertise in Narcolepsy, Drowsiness, and Excessive Daytime Sleepiness. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Sleep Medicine.

Does Dr. Emmanuel Mignot participate in research or clinical trials?

Yes. Dr. Emmanuel Mignot has published 263 articles and abstracts on conditions like Narcolepsy. You can view a list of Dr. Emmanuel Mignot's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Emmanuel Mignot accept my insurance?

Dr. Emmanuel Mignot accepts most major insurance plans, including Aetna and Blue Cross Blue Shield. We recommend calling the office directly at 650-723-6601 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Mignot's expertise for a condition
ConditionClose
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile